Faeth Therapeutics, Inc: William Blair initiates coverage with outperform rating
FTH•William Blair initiated coverage of Faeth Therapeutics, Inc with an outperform rating.
Related News
European stocks rise, dollar set for weekly loss after yields drop
SPY•
Walker & Dunlop publishes update to financial calendar
WD•
Varonis Systems: Rosenblatt Securities cuts to neutral from buy, lowers target price to $49.75 from $55
VRNS•
Wall Street futures mixed as tech wobbles again, Tesla gains
SPY•
Travelers year-to-date 2026 net income jumps 54% to $5.84 billion
TRV•